We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Urged to Clarify Voluntary Quality Standards for Combination Products
FDA Urged to Clarify Voluntary Quality Standards for Combination Products
A trade group representing combination drug products is urging the FDA to draw bright lines among the agency’s centers as it considers voluntary quality standards.